993 related articles for article (PubMed ID: 24314824)
1. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG.
Smorenburg CH; de Groot SM; van Leeuwen-Stok AE; Hamaker ME; Wymenga AN; de Graaf H; de Jongh FE; Braun JJ; Los M; Maartense E; van Tinteren H; Nortier JWR; Seynaeve C
Ann Oncol; 2014 Mar; 25(3):599-605. PubMed ID: 24504445
[TBL] [Abstract][Full Text] [Related]
3. Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: final results of the DOGMES multicentre GINECO trial.
Falandry C; Brain E; Bonnefoy M; Mefti F; Jovenin N; Rigal O; Guillem O; El Kouri C; Uwer L; Abadie-Lacourtoisie S; Cretin J; Jacquin JP; Paraiso D; Freyer G
Eur J Cancer; 2013 Sep; 49(13):2806-14. PubMed ID: 23735702
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
Riccio D; Solinas A; Astara G; Mantovani G
Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy.
Aaldriks AA; Maartense E; le Cessie S; Giltay EJ; Verlaan HA; van der Geest LG; Kloosterman-Boele WM; Peters-Dijkshoorn MT; Blansjaar BA; van Schaick HW; Nortier JW
Crit Rev Oncol Hematol; 2011 Aug; 79(2):205-12. PubMed ID: 20709565
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and toxicity profile of pegylated liposomal doxorubicin (Caelyx) in patients with advanced breast cancer.
Rom J; Bechstein S; Domschke C; Golatta M; Mayer C; Heil J; Thum J; Smetanay K; Windemuth-Kieselbach C; Wallwiener M; Marme F; Schuetz F; Sohn C; Schneeweiss A
Anticancer Drugs; 2014 Feb; 25(2):219-24. PubMed ID: 24247203
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience.
Gironés R; Torregrosa D; Díaz-Beveridge R
Crit Rev Oncol Hematol; 2010 Mar; 73(3):236-45. PubMed ID: 19748793
[TBL] [Abstract][Full Text] [Related]
8. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Brain EG; Mertens C; Girre V; Rousseau F; Blot E; Abadie S; Uwer L; Bourbouloux E; Van Praagh-Doreau I; Mourey L; Kirscher S; Laguerre B; Fourme E; Luneau S; Genève J; Debled M
Crit Rev Oncol Hematol; 2011 Oct; 80(1):160-70. PubMed ID: 21035352
[TBL] [Abstract][Full Text] [Related]
9. [Cancer treatment in elderly patients: evidence and clinical research].
Repetto L; Luciani A
Recenti Prog Med; 2015 Jan; 106(1):23-7. PubMed ID: 25621776
[TBL] [Abstract][Full Text] [Related]
10. Geriatric factors predict chemotherapy feasibility: ancillary results of FFCD 2001-02 phase III study in first-line chemotherapy for metastatic colorectal cancer in elderly patients.
Aparicio T; Jouve JL; Teillet L; Gargot D; Subtil F; Le Brun-Ly V; Cretin J; Locher C; Bouché O; Breysacher G; Charneau J; Seitz JF; Gasmi M; Stefani L; Ramdani M; Lecomte T; Mitry E
J Clin Oncol; 2013 Apr; 31(11):1464-70. PubMed ID: 23460711
[TBL] [Abstract][Full Text] [Related]
11. Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.
Honecker F; Harbeck N; Schnabel C; Wedding U; Waldenmaier D; Saupe S; Jäger E; Schmidt M; Kreienberg R; Müller L; Otremba B; Dorn J; Warm M; Al-Batran SE; de Wit M;
J Geriatr Oncol; 2018 Mar; 9(2):163-169. PubMed ID: 29055624
[TBL] [Abstract][Full Text] [Related]
12. Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
Kamal AH; Camacho F; Anderson R; Wei W; Balkrishnan R; Kimmick G
Breast Cancer Res Treat; 2012 Jul; 134(1):371-8. PubMed ID: 22460617
[TBL] [Abstract][Full Text] [Related]
13. Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Leo S; Arnoldi E; Repetto L; Coccorullo Z; Cinieri S; Fedele P; Cazzaniga M; Lorusso V; Latorre A; Campanella G; Ciccarese M; Accettura C; Pisconti S; Rinaldi A; Brunetti C; Raffaele M; Coltelli L; Spazzapan S; Fratino L; Petrucelli L; Biganzoli L
Oncologist; 2019 Jun; 24(6):e232-e240. PubMed ID: 30413667
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of geriatric assessment in older patients with advanced breast cancer receiving chemotherapy.
Aaldriks AA; Giltay EJ; le Cessie S; van der Geest LG; Portielje JE; Tanis BC; Nortier JW; Maartense E
Breast; 2013 Oct; 22(5):753-60. PubMed ID: 23414850
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive geriatric assessment and its clinical impact in oncology.
Maas HA; Janssen-Heijnen ML; Olde Rikkert MG; Machteld Wymenga AN
Eur J Cancer; 2007 Oct; 43(15):2161-9. PubMed ID: 17855074
[TBL] [Abstract][Full Text] [Related]
16. [Palliative chemotherapy for metastatic breast cancer with capecitabine].
Inaba T; Kashiwaba M; Takeda Y; Komatsu H; Tomisawa Y; Takiyama I; Wakabayashi G
Gan To Kagaku Ryoho; 2009 May; 36(5):769-72. PubMed ID: 19461175
[TBL] [Abstract][Full Text] [Related]
17. Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.
Baitar A; Van Fraeyenhove F; Vandebroek A; De Droogh E; Galdermans D; Mebis J; Schrijvers D
J Geriatr Oncol; 2014 Apr; 5(2):179-84. PubMed ID: 24495700
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.
Park S; Hong J; Hwang I; Ahn JY; Cho EY; Park J; Cho EK; Shin DB; Lee JH
J Geriatr Oncol; 2015 Nov; 6(6):470-8. PubMed ID: 26522808
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.
Blum JL; Barrios CH; Feldman N; Verma S; McKenna EF; Lee LF; Scotto N; Gralow J
Breast Cancer Res Treat; 2012 Dec; 136(3):777-88. PubMed ID: 23104222
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
